Endometriosis research in focus on the airwaves
By Rob Clancy, staff writer
Hudson Institute’s endometriosis research was in focus on Melbourne airwaves over the weekend, as long-running radio science program Einstein A-Go-Go devoted its whole hour to the disease.
As part of Endometriosis Awareness Month Hudson’s own Dr Fiona Cousins joined a panel of experts to discuss the challenges and successes of endo research as well as the realities of living with endometriosis.
Among the worrying facts shared were that endometriosis affects as many Australians as asthma and diabetes, but receives only a fraction of the research funding that’s available for those conditions.
Living with endometriosis
Dr Cousins discussed the research under way at Hudson Institute into earlier detection of endometriosis and better methods of treatment, including her own work on harnessing the immune system to tackle endometrial lesions, in place of surgery.
Other Einstein A-Go-Go guests included the CEO of Endometriosis Australia, Maree Davenport, surgeon Dr Kate Tyson from Epworth Hospital and President of the Australasian Society for Ultrasound in Medicine Alison Deslandes.
Listeners also heard from speaker and writer, Kate Kenfield, about her experience living with endometriosis and the enormous impact it has had on many aspects of her life.
Subscribe to ENDO newsletter
The program was sponsored by Hudson Institute and anyone with an interest in endometriosis can subscribe to our ENDO Newsletter at this link.
Einstein A-Go-Go is the resident science program on Melbourne community radio station 3RRR, which has run every Sunday for more than 20 years, hosted by Dr Shane Huntington (Dr Shane) and Associate Professor Jen Martin (Dr Jen).
In this article
About Hudson Institute
Hudson Institute’ s research programs deliver in three areas of medical need – inflammation, cancer, women’s and newborn health. More
Hudson News
Get the inside view on discoveries and patient stories
“Thank you Hudson Institute researchers. Your work brings such hope to all women with ovarian cancer knowing that potentially women in the future won't have to go through what we have!”